FindTrial
Sign In

A comparative study on the diagnostic value of optical enhanced endoscopy combined with magnifying endoscopy and acetic acid enhanced magnifying endoscopy in metaplasia of gastric mucosa and intestinal epithelium

A comparative study on the diagnostic value of optical enhanced endoscopy combined with magnifying endoscopy and acetic acid enhanced magnifying endoscopy in metaplasia of gastric mucosa and intestinal epithelium

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032072
Enrollment
Unknown
Registered
2020-04-19
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal adenoma

Interventions

acid&#32
endoscopy.
Acetic&#32
Gold Standard:Histological examination
Index test:1.&#32
Optical&#32
enhanced&#32
endoscopy&#32
combined&#32
with&#32
magnifying&#32
endoscopy
2.&#32

Sponsors

Zhengzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with Ag and GM confirmed by previous histopathology; 2. Patients with HP infection, aged >= 40 years old and dyspepsia have been confirmed in the past.

Exclusion criteria

Exclusion criteria: 1. Patients with gastrointestinal bleeding, history of gastrectomy and advanced gastric cancer; 2. Patients who can not tolerate endoscopy, including coagulation dysfunction; 3. Allergic to acetic acid or narcotic drugs.

Design outcomes

Primary

MeasureTime frame
Detection rate of intestinal metaplasia;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactHuili Wu

Zhengzhou Central Hospital

wuhuili616161@126.com+86 13803815665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026